LGGs are further subdivided based on 1p19q codeletion for oligodendrogliomas (OD) and frequent mutations in TP53 and ATRX for astrocytomas (AS).2 Gliomas most often display the R132H mutation in IDH1. This evidence concerns the gene IDH1 and central nervous system cancer.